[go: up one dir, main page]

PE20001241A1 - Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores - Google Patents

Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores

Info

Publication number
PE20001241A1
PE20001241A1 PE1999001155A PE00115599A PE20001241A1 PE 20001241 A1 PE20001241 A1 PE 20001241A1 PE 1999001155 A PE1999001155 A PE 1999001155A PE 00115599 A PE00115599 A PE 00115599A PE 20001241 A1 PE20001241 A1 PE 20001241A1
Authority
PE
Peru
Prior art keywords
tumors
treatment
alkyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
PE1999001155A
Other languages
English (en)
Inventor
Frederick Ray Kinder Jr
Christopher Turchik Jagoe
Richard William Versage
Sompong Wattanasin
Kenneth Walter Bair
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20001241A1 publication Critical patent/PE20001241A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS CAPROLACTAMAS DE FORMULA I, DONDE R1 ES ALQUILO C1-C6, CICLOALQUILO C3-C6; R2 ES H, ALQUILO C1-C6; X ES ALQUILENO C1-C12, ALQUENILENO C2-C12, ALQUINILENO C2-C12; m ES 0-1; R3 ES CICLOALQUILO C3-C8, ANILLO AROMATICO DE FORMULA II, III, V; R4 ES H, Cl, METOXILO; R5 ES H, Cl, ALQUILO C1-C18, ALCOXILO C1-C18; Z ES O, S, NH, NCH3. SON COMPUESTOS PREFERIDOS 3,4,5-TRIHIDROXI-2-METOXI-8,8-DIMETIL-N-[HEXAHIDRO-2-OXO-6-(CICLOHEXILCARBONIL)OXI-2H-AZEPIN-3-IL]NON-6-ENAMIDA; 3,4,5-TRIHIDROXI-2-METOXI-8,8-DIMETIL-N-[HEXAHIDRO-2-OXO-6-(1-OXO-3-FENILPROPOXI)-2H-AZEPIN-3-IL]NON-6-ENAMIDA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN QUIMIOTERAPEUTICO Y PUEDE SER UTIL PARA EL TRATAMIENTO DE TUMORES
PE1999001155A 1998-11-17 1999-11-15 Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores PE20001241A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19335498A 1998-11-17 1998-11-17

Publications (1)

Publication Number Publication Date
PE20001241A1 true PE20001241A1 (es) 2000-11-24

Family

ID=22713307

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001155A PE20001241A1 (es) 1998-11-17 1999-11-15 Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores

Country Status (25)

Country Link
EP (1) EP1131297B1 (es)
JP (1) JP3550545B2 (es)
KR (1) KR20010080461A (es)
CN (1) CN1187333C (es)
AR (1) AR023914A1 (es)
AT (1) ATE264309T1 (es)
AU (1) AU748016B2 (es)
BR (1) BR9915436A (es)
CA (1) CA2347773C (es)
CO (1) CO5140099A1 (es)
CZ (1) CZ20011707A3 (es)
DE (1) DE69916488T2 (es)
ES (1) ES2221463T3 (es)
HU (1) HUP0104224A3 (es)
ID (1) ID28343A (es)
IL (1) IL142701A0 (es)
NO (1) NO20012428L (es)
PE (1) PE20001241A1 (es)
PL (1) PL347633A1 (es)
PT (1) PT1131297E (es)
SK (1) SK6692001A3 (es)
TR (1) TR200101366T2 (es)
UY (2) UY25807A1 (es)
WO (1) WO2000029382A1 (es)
ZA (1) ZA200103419B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001295206A1 (en) * 2000-05-11 2001-11-20 Novartis Ag Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
US6545148B2 (en) 2001-03-12 2003-04-08 Novartis Ag Process for preparing certain substituted caprolactams
BRPI0412843A (pt) * 2003-07-25 2006-09-26 Novartis Ag lactamas substituìdas e uso das mesmas como agentes anticáncer
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
EP2582681A1 (en) 2010-06-17 2013-04-24 Novartis AG Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
CN102947274A (zh) 2010-06-17 2013-02-27 诺瓦提斯公司 联苯基取代的1,3-二氢-苯并咪唑-2-亚基胺衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge

Also Published As

Publication number Publication date
NO20012428L (no) 2001-07-17
ID28343A (id) 2001-05-17
CO5140099A1 (es) 2002-03-22
NO20012428D0 (no) 2001-05-16
DE69916488D1 (de) 2004-05-19
DE69916488T2 (de) 2005-03-24
ATE264309T1 (de) 2004-04-15
WO2000029382A1 (en) 2000-05-25
UY26036A1 (es) 2001-06-29
HUP0104224A2 (hu) 2002-03-28
JP3550545B2 (ja) 2004-08-04
CZ20011707A3 (cs) 2001-08-15
AU748016B2 (en) 2002-05-30
IL142701A0 (en) 2002-03-10
CA2347773C (en) 2009-03-10
CN1326445A (zh) 2001-12-12
JP2002529536A (ja) 2002-09-10
AR023914A1 (es) 2002-09-04
AU1506000A (en) 2000-06-05
CA2347773A1 (en) 2000-05-25
PT1131297E (pt) 2004-08-31
PL347633A1 (en) 2002-04-22
HUP0104224A3 (en) 2002-04-29
KR20010080461A (ko) 2001-08-22
UY25807A1 (es) 2001-08-27
ZA200103419B (en) 2002-06-26
EP1131297B1 (en) 2004-04-14
TR200101366T2 (tr) 2001-10-22
CN1187333C (zh) 2005-02-02
EP1131297A1 (en) 2001-09-12
SK6692001A3 (en) 2001-10-08
BR9915436A (pt) 2001-08-07
ES2221463T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
FI915282A0 (fi) Mono-n-substituerade 1,4,7,10-tetra -azacyklododekanderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
BG102792A (bg) Производни на заместени 4-хидроксифенилалканоилови киселини с агонистична активност към рраr-гама
PE115999A1 (es) Secretagogos de la hormona del crecimiento
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
DE69428476D1 (de) Heterocyclische Verbindungen als Bradykinin Antagonisten
PE20020228A1 (es) Compuestos organicos como inhibidores de 3',5' guanosin monofosfato ciclico fosfodiesterasa
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
PE20001241A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
ES2091471T3 (es) Agentes procineticos a base de lactama macrociclica.
NO308532B1 (no) Farmasøytiske piperazinforbindelser
BG105123A (en) Tetrahydroquinaline derivatives as glycine antagonists
PE51499A1 (es) Derivados de 5-aroilnaftaleno
ATE46511T1 (de) Neue 8-alkylthio-2-piperazino-pyrimido(5,4d>pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel.
FI875145A0 (fi) Kondenserade heterocykliska tetrahydroaminokinoliner och beslaektade foereningar, en metod foer deras framstaellning och deras anvaendning som mediciner.
DK1257552T3 (da) Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose
SE8303913L (sv) Heterocykliska foreningar
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ATE215075T1 (de) Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend
AR010200A1 (es) Derivados de aza-antraciclinona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE203533T1 (de) INDOLDERIVATE ALS PRODRUGS VON ß5-HT1-LIKEß REZEPTOR AGONISTEN
GB9315018D0 (en) Chemical compounds
ES2192342T3 (es) 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.

Legal Events

Date Code Title Description
FC Refusal